Los Angeles, CA: The adjunctive administration of the proprietary, plant-derived CBD extract Epidiolex is associated…
The long-term use of Epidiolex is associated with reduced seizure frequency in a subset of patients with pediatric, refractory epilepsy…
“This novel study can catalyze the use of CBD as an alternative analgesic to opioids for acute inflammatory pain conditions, which could ultimately help to address the opioid epidemic.”
“In all three studies, over 80 percent of assessed patients with severe spasticity at baseline reported a shift into a lower category of spasticity after 12 weeks.”
“Sublingual CBD was found to be well-tolerated and provided statistically significant improvements in several BPS parameters,” investigators determined.
“These encouraging results suggest that further multicenter, larger, randomized, controlled trials of longer-term are warranted.”
The agency had previously opined that regulating hemp-derived CBD products as dietary supplements could potentially discourage the use and development of CBD prescription drugs.
Over 90 percent of subjects treated with the combination therapy experienced a ≥50 percent reduction in seizure frequency at six-months.